Skip to main content
. 2018 Aug 6;8:11739. doi: 10.1038/s41598-018-30168-4

Figure 3.

Figure 3

Correlation Between OCT4 and NANOG Expressions and Survival Rates in Patients with Renal Cell Carcinoma. Progression-free survival (PFS) with nuclear OCT4 (a) and cytoplasmic NANOG (b) expressions (Nuclear and cytoplasmic expressions were grouped into low- vs. moderate- vs. high-expression levels).